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Hepatitis B virus X protein is a major factor in the HBV-induced disease developments. Stromal cell-
derived factor-1 is a small cytokine that is strongly chemotactic for lymphocytes. We explored the
role of HBx on recruitment of HBV-induced virus-nonspeciﬁc immune cells into liver. Immune cell
recruitment and SDF-1 expression level signiﬁcantly increased in livers of HBx-transgenic mice and
X-box binding protein-1 signiﬁcantly increased SDF-1 gene expression. Finally, we conﬁrmed that
immune cell recruitment into liver tissues of HBx-TG mice was diminished by a chemokine receptor
antagonist. Therefore, HBx increases ER stress-dependent SDF-1 expression and induces HBV-
induced immune cell recruitment into liver.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hepatitis B virus (HBV) is a non-cytopathic virus that causes
acute and chronic necroinﬂammatory liver diseases [1–3], often
leading to the development of cirrhosis and hepatocellular carci-
noma [1,2]. HBV-speciﬁc cytotoxic T lymphocytes (CTLs) play a
major role in viral clearance during acute infection or the early
stages of liver disease [4,5]. However, depletion of CTLs delays
the onset of biochemical, histological, and clinical evidence of
hepatitis [5]. Therefore, HBV-speciﬁc CTLs may play additional
functions during HBV infection. For instance, activated CTLs are
known to produce cytokines such as interferon-c, which recruit
large numbers of virus-nonspeciﬁc inﬂammatory cells into the li-
ver via chemokine induction [6]. These chemokine-recruited
virus-nonspeciﬁc mononuclear cells (i.e., natural killer (NK) cells,
natural killer T (NKT) cells, T and B lymphocytes, monocytes, mac-
rophages, and dendritic cells) can contribute to the formation of
necroinﬂammatory foci and virus-speciﬁc CTLs are outnumbered
by host-derived mononuclear and polymorphonuclear inﬂamma-
tory cells [7].
Chemokines are 8–14 kDa peptides that function as chemoat-
tractant cytokines in cell activation, immune cell differentiation,
and leukocyte trafﬁcking. Chemokines bind to speciﬁc Gprotein-coupled receptors, also known as seven-transmembrane
domain receptors [8]. The chemokine stromal cell-derived factor-
1 (SDF-1) is constitutively expressed in several tissues, including
the liver, lung, kidney, bone marrow, etc., and exhibits chemoat-
tractive activity for T cells, precursor B cells, monocytes, and neu-
trophils [9]. SDF-1 exerts pleiotropic effects, regulating embryonic
life, tissue homeostasis, immune surveillance, inﬂammatory re-
sponses, and cancer development [10], and it is also associated
with tissue damage, especially liver damage, heart infarct, limb
ischemia, etc. [11]. Furthermore, SDF-1 plays a proinﬂammatory
role in several autoimmune diseases, particularly rheumatoid
arthritis and nephritis in murine lupus [12,13].
The endoplasmic reticulum (ER) is involved in sequestration of
calcium, lipid synthesis, facilitation of protein folding, and
transport of synthesized proteins [14]. ER stress is induced by
the accumulation of unfolded or misfolded proteins in the ER
lumen. A plethora of evidence suggests that there is an extensive
cross-talk between the ER stress response and inﬂammatory
response [15]. In support of this, we previously reported that
HBx induces ER stress via reduction of the cellular ATP level, there-
by disrupting proper folding of many secretary proteins, and that
activating transcription factor-4 (ATF4) induced by ER stress
elevates inﬂammatory cytokine production [16]. In this study, we
report that HBx induces production of chemoattractant cytokines
via ER stress, resulting in recruitment of HBV-induced virus-
nonspeciﬁc immune cells into the liver.
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2.1. Plasmid constructs and reagents
pGL3B-SDF-1-luc (1914 to +1) was described previously [17].
AP-1 luc was generously provided by J.W. Lee (Chungbuk National
University, Korea). pcDNA3-HBx, pcDNA3-HBV 1.2mer, pcDNA3-
HBV(-x) 1.2mer, pCMV5-myc-ATF4 and pcDNA-HA-CREBH(n) were
described previously [16]. pcDNA3-HA-ATF6a(n), pcDNA3-ﬂag-
XBP1(s) and pAdTrack-CMV were kindly gifted from Dr. K.H. Kim
(Sungkyunkwan University School of Medicine, Korea). Trimethyl-
amine N-oxide (TMO), thapsigargin and tunicamycin were pur-
chased from Sigma (Steinheim, Germany). The transfection
reagent jetPEI and jetPRIME were purchased PolyPlus Transfection
(Strasbourg, France).
2.2. Cell culture and HBx transgenic mice
XBP1 +/+ and XBP1 / MEF were kindly gifted from Dr. S.H.
Back (Ulsan University, Korea). The MEF cells were maintained in
DMEM containing 10% FBS, 1% PS and 1% non-essential amino acid
(Gibco) at 37 C in a humid atmosphere of 5% CO2. B6 transgenic
mice liver tissues expressing HBx (n = 19) and their non-transgenic
sibs (C57BL/6, n = 12) were described previously [18].
2.3. Construction of recombinant adenovirus carrying HBx
To construct a recombinant adenovirus Ad-HBx, we performed
sub-cloning from pcDNA3-HBx to pAdTrack-CMV. pcDNA3-HBx
was digested with EcoRI and XhoI, and the products were cloned
into the EcoRI/XhoI sites of pAdTrack-CMV. pAdTrack-CMV or pAd-
Track-CMV-HBx digested with PmeI (New England Biolabs, Hitchin,
Hertfordshire, UK) was transformed into BJ5183-AD-1 (New Eng-
land Biolabs) competent cell for homologous recombination with
pAdEasy-1. The puriﬁed recombinant adenoviral plasmids was di-
gested with PacI (New England Biolabs), and then it was transfec-
ted into 293-AD cells. Recombinant Adenovirus was obtained
through lysis of the transfected 293-AD cells, and then the adeno-
virus was ampliﬁed. Recombinant adenovirus with a titer of
2.3  108 pfu/ml was collected, and then we added recombinant
adenovirus at the concentration of 7  104 or 7  105 pfu/ml to
the medium.
2.4. Luciferase assay
Cells were seeded in 24-well culture plate and transfected
with reporter vector and b-galactosidase expression plasmid,
along with each indicated expression plasmids using JetPEI. Total
amounts of expression vectors were kept constant by pcDNA3.1
(Invitorgen, Carlsbad, CA, USA). After 24 h of transfection, cells
were incubated in the presence or absence of TMO, thapsigargin
or tunicamycin for 12 h. After 36 h of transfection, the cells were
lysed in the cell culture lysis buffer (Promega, Madison, WI,
USA). Luciferase activity was determined using an analytical
luminescence luminometer according to the manufacturer’s
instructions. Luciferase activity was normalized for transfection
efﬁciency using the corresponding b-galactosidase activity. All
assays were performed at least in triplicate.
2.5. RNA isolation, RT (reverse transcriptase)-PCR and real-time PCR
analysis
Total RNA was prepared from cell lines or tissues using Trizol
reagent (Invitrogen) following the manufacturer’s instructions. To-
tal RNA (1 lg) was converted into single strand cDNA by MMLV re-
verse transcriptase (Takara, Tokyo, Japan) with oligo-dT. A one-tenth aliquot of the cDNA was subjected to PCR ampliﬁcation using
gene speciﬁc primers. The PCR products were examined by electro-
phoresis on a 1.2% agarose gel. Real-time PCR was performed with
an SYBR Green I LightCycler-based real-time PCR assay (Roche,
Mannheim, Germany). The reaction mixtures were prepared using
LightCycler Fast DNA master mixture for SYBR Green I, 0.5 lM of
each primer and 4 mM MgCl2. PCR was carried out using the fol-
lowing forward and reverse primers: SDF-1 F, 50-GCC AGA GCC
AAC GTC AAG CAT-30; SDF-1 R, 50-CTT GTT TAA AGC TTT CTC
CAG GTA CTC-30. The primers of actin, BIP, HBx, and XBP1 were de-
scribed previously [16]. The number of wild type and HBx-TG used
in RT-PCR was twelve mice, respectively.
2.6. Western blot analysis
The cells were prepared by washing with cold-PBS and lysed.
The protein concentration was determined using the BSA as stan-
dard and Bradford reagent (Bio-Rad). Equal amount of proteins
was loaded and separated by SDS–PAGE and the gels were trans-
ferred to polyvinylidene ﬂuoride membrane (Millipore, Billerica,
MA, USA). For western blotting, the membranes were incubated
with anti-HBx (Chemicon, Temecula, CA, USA), anti-SDF-1 (R&D
system, Minneapolis, MN, USA), anti-ﬂag (Cell signaling, Beverly,
MA, USA), anti-XBP1 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and anti-actin (Sigma) in TBST supplemented with 3%
non-fat dry skim milk for overnight at 4 C. After washing three
times with cold TBST, the blotted membranes were incubated
with peroxidase conjugated secondary antibody (Santa Cruz Bio-
technology) for 30 min at room temperature. After washing three
times with cold TBST, the proteins were visualized by the en-
hanced chemiluminescent development reagent (Amersham
Pharmacia Biotech, Piscataway, NJ, USA). The number of wild
type and HBx-TG used in Western blotting was twelve mice,
respectively.
2.7. Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed as described by the manufacturer
(Upstate Biotechnology, Lake Placid, NY) with some modiﬁcations.
Chromatin solutions were sonicated and incubated with anti-ﬂag,
or with control IgG, and rotated overnight at 4 C. Chromatin
DNA was puriﬁed and subjected to PCR analysis. To amplify the
human SDF-1 promoter region containing TRE site, the following
primer sets were used; p-803, 50-ACG ATG CAG AGA ATT TCG
CGG CGT-30; p-613, 50-ACC AGC CGA GCC TCA GTT TCC TCG-30.
As a negative control, human SDF-1 promoter region non-
containing TRE site was used, the following primer sets were used;
p-1139, 50-GCG GTC ACA AAG CGA GGC CCA AA-30; p-953, 50-CTG
GCG TCT GCC TTC TGG GTC CAG-30. After ampliﬁcation, PCR
products were resolved on a 1.5% agarose gel and visualized by
ethidium bromide staining.
2.8. AMD 3100 injection
Male HBx transgenic mice (12-weeks old, n = 7) were injected
subcutaneously with AMD 3100 (1.25 mg/kg in 200 ll of PBS,
n = 4) or PBS (n = 3) twice per day for 10 days.
2.9. H&E stain
The liver tissues of wild-type (n = 4) or HBx transgenic
mice (not injected mice, n = 4; AMD-injected mice, n = 4;
PBS-injected mice, n = 3) were ﬁxed in 4% prarformaldehyde. The
parafﬁn-embedded tissue sections were mounted on 3-amino-
propyltriethoxylsilane-coated slides. Dewaxed parafﬁn sections
were rehydrated in each 100%, 95% and 70% ethanol during
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for nuclear and cytoplasm stain, respectively.
2.10. Statistical analysis
Statistical analyses were carried out by unpaired or paired t test
as appropriate. All data are reported as means ± S.D. P value of
<0.05 was considered signiﬁcant.
3. Results
3.1. Immune cell recruitment to the liver is increased in HBx transgenic
mice
To examine hepatic inﬂammation induced by HBx, we prepared
wild-type and HBx-transgenic (TG) mice and analyzed hepatic
inﬂammation in liver tissues at different developmental stages.
For this, inﬂammatory parameters in livers were assessed. Degree
of hepatic inﬂammation was graded on a scale from 0 to 4 based
on region (lobular, portal, and interface), and the number of lobes
withP5 inﬂammatory foci was noted. The summation of these cat-
egorical inﬂammatory scores resulted in a hepatitis index; mice
with a score P4 were deﬁned as having hepatitis. To investigate
the effect of HBx on recruitment of immune cells into liver tissues,
H&E staining was performed on liver tissues of wild-type and
HBx-TG (HBx copy number in the liver tissues, 2.9796  107/total
RNA 1 lg) mice aged 11–12 weeks. As a result, inﬁltration of im-
mune cells was signiﬁcantly higher in liver tissues of HBx-TG mice
compared to those of wild-typemice (Fig. 1A). These results suggest
that HBx induces recruitment of immune cells into liver tissues.
3.2. Expression of SDF-1 is increased in HBx-expressing cells and mice
We next investigated the level of SDF-1 expression in livers of
HBx-TG mice, as SDF-1 is constitutively expressed in the liver
and exhibits chemoattractive activity for T cells and monocytes
[9]. As shown in Fig. 2A and B, SDF-1 expression was signiﬁcantly
higher in HBx-TG mice compared to the control. To determine the
association between SDF-1 over-expression in HBx-TG mice and
HBx, luciferase reporter assay for SDF-1 promoter activation was
performed with expression plasmids for HBx, HBV1.2 encoding a
1.2mer of the HBV genome, or HBV1.2 (HBx-) encoding a 1.2mer
of the HBx-deﬁcient HBV genome. The expression level of SDF-1 in-
creased in both HBx- and HBV1.2-transfected cells compared to
mock-transfected cells, but not in HBV1.2 (HBx-) transfected cells
(Fig. 2C). In addition, to investigate the mRNA and protein expres-
sion levels of SDF-1, we transduced HBX-expressing recombinantFig. 1. Recruitment of immune cells into the liver is increased in HBx-TG mice. H&E stain
and HBx-TG (n = 4) mice.adenoviruses (Ad-HBx) into HepG2 cells. We observed that SDF-1
expression was largely up-regulated by HBx (Fig. 2D and E). These
results suggest that HBx can induce SDF-1 expression in the liver.
3.3. HBx-induced SDF-1 expression is mediated by ER stress
SDF-1 is known to mediate proinﬂammatory effects, and ER
stress is closely related with inﬂammation. Therefore, based on
our previous ﬁnding that HBx induces ER stress [16], we investi-
gated whether or not HBx-induced SDF-1 expression is related to
ER stress. As shown in Fig. 3A, luciferase activity for SDF-1
promoter activation was enhanced by the ER stress inducers
thapsigargin, an inhibitor of intracellular Ca2+ pumps, and tunica-
mycin, an inhibitor of protein glycosylation and palmitoylation.
The mRNA and protein expression levels of SDF-1 were also
elevated by the ER stress inducers (Fig. 3B and C).
To further conﬁrm that ER stress increases HBx-induced SDF-1
expression, we used trimethylamine N-oxide (TMO), a chemical
chaperone that attenuates ER stress. As shown in Fig. 3D, HBx-en-
hanced luciferase activity of the SDF-1 promoter was reduced by
TMO treatment. Consistent with this, the mRNA and protein
expression levels of SDF-1 elevated by HBx were also abrogated
by TMO treatment (Fig. 3E and F). These results suggest that
HBx-induced SDF-1 over-expression is associated with ER stress.
3.4. ER stress regulator XBP1 increases SDF-1 expression
The ER stress response activates a set of signaling pathways,
including the activating transcription factor-6 (ATF6), PKR-like ER
kinase (PERK), and inositol-requiring enzyme-1 (IRE1) pathways.
Master transcriptional factors of these pathways include ATF6 nu-
clear form, XBP1 spliced form, and ATF4, respectively. In addition
to these transcription factors, CCAAT/enhancer-binding protein
homologous protein (CHOP) was tested to identify a transcription
factor that can regulate SDF-1 expression. As shown in Fig. 4A,
SDF-1 promoter activity was signiﬁcantly enhanced by XBP1
spliced form. The mRNA and protein expression levels of SDF-1
were also increased by XBP1 spliced form (Fig. 4B and C). To inves-
tigate the molecular mechanism of SDF-1 induction by XBP1, we
analyzed the promoter of SDF-1 gene. As a result, we found AP1
binding element on SDF-1 promoter and the paper that XBP1 was
identiﬁed as protein binding a cis element called the X box (a
classic CRE/AP1 sequence in the human major histocompatibility
complex class II DRA gene and in the mouse Aa gene) [19]. There-
fore, to investigate whether XBP1 increases AP1 luciferase activity
and binds on AP1 element, luciferase and ChIP assays were per-
formed, respectively. XBP1 signiﬁcantly increased AP1 luciferaseing was performed with parafﬁn-embedded liver tissue sections of wild-type (n = 4)
Fig. 2. HBx increases SDF-1 expression. (A and B) SDF-1 expression levels in wild type (n = 12) and HBx-TG (n = 12) mice were examined by RT-PCR (A) or Western blotting
(B) of tissues lysates. Actin was used as a loading control for RT-PCR andWestern blotting. (C) HBx enhances SDF-1 promoter activation. HepG2 or Huh7 cells were transfected
with SDF-1 luciferase reporter and the indicated genes. After 30 h of transfection, cell lysates were analyzed for luciferase activity. ⁄⁄P < 0.01 compared with mock-transfected
cells, and #P < 0.05, ##P < 0.01 compared with HBV (HBx-) transfected cells. (D and E) Ad-Con or Ad-HBx was treated to culture medium of HepG2 cells. After 28 or 34 h, cell
lysates were subjected to RT-PCR (D) or Western blotting (E), respectively. Actin was used as a loading control for RT-PCR and Western blotting.
Fig. 3. HBx-induced SDF-1 expression is mediated by ER stress. (A) HepG2 cells were transfected with SDF-1 luciferase reporter, after which thapsigargin (1 lM) or
tunicamycin (3 mg/ml) was treated to cells for 12 h. Cell lysates were then analyzed for luciferase activity. ⁄⁄P < 0.01 compared with DMSO-treated cells. (B and C) HepG2 cells
were treated with thapsigargin (1 lM) or tunicamycin (3 mg/ml) for 12 h. Cell lysates were subjected to RT-PCR (B) or Western blotting (C). XBP1 and BIP were used as ER
stress markers. (D) HepG2 cells were transfected with SDF-1 promoter reporter along with mock or HBx vector, after which TMOwas treated to cells for 24 h. Cell lysates were
analyzed for luciferase activity. ⁄⁄P < 0.01, ⁄P < 0.05 compared with the indicated cells. (E and F) Ad-Con or Ad-HBx was treated to culture medium of HepG2 cells for 2 h, after
which the culture medium was exchanged for fresh medium containing TMO (25 mM). After 28 or 34 h, cell lysates were subjected to real-time PCR (E) or Western blotting
(F), respectively. Expression levels in real-time PCR were normalized relative to Actin. ⁄P < 0.05, ⁄⁄P < 0.01 compared with the indicated cells.
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Fig. 4. ER stress regulator XBP1 increases SDF-1 expression. (A) HepG2 cells were transfected with SDF-1 promoter reporter and the indicated genes, after which cell lysates
were analyzed for luciferase activity. ⁄⁄P < 0.01 compared with mock-transfected cells. Abbreviations are as follows: ATF6 (n), ATF6 nuclear form; XBP1 (s), XBP1 splicing
form; CREBH (n), CREBH nuclear form. (B and C) HepG2 cells were transfected with mock or HBx vectors, after which cell lysates were subjected to RT-PCR (B) or Western
blotting (C), respectively. (D) HepG2 cells were transfected with reporter gene containing AP1 binding element, along with mock or XBP1(s) vector for 24 h. The cell lysates
were analyzed for luciferase activity. ⁄⁄P < 0.01, ⁄P < 0.05 compared with indicated cells. (E) The schematic diagram depicts the location of AP1 binding and non-binding
elements in SDF-1 promoter. (F) The ChIP assay for XBP1(s) recruitment on the SDF-1 native promoter DNA. Empty vector pcDNA3-ﬂag and pcDNA3-ﬂag-XBP1(s) expression
vector were transfected into HepG2 cells. Following formaldehyde cross-linking, soluble chromatin was prepared. After immunoprecipitation with ﬂag antibody, the
precipitated DNAs were used in PCR analysis.
Fig. 5. HBx-induced SDF-1 expression is mediated by XBP1. (A) HepG2 cells were transfected with mock or HBx expression plasmid, along with siCon or siXBP1, after which
cell lysates were subjected to Western blotting. (B) XBP1 +/+ or / MEFs were transfected with SDF-1 luciferase reporter, along with mock or HBx vectors, after which cell
lysates were analyzed for luciferase activity. ⁄⁄P < 0.01 compared with the indicated cells. (C and D) Ad-Con or Ad-HBx was treated to culture medium of XBP1 +/+ or /
MEFs. After 30 or 36 h, cell lysates were subjected to real-time PCR (C) or Western blotting (D), respectively. Expression levels in real-time PCR were normalized relative to
Actin. ⁄⁄P < 0.01 compared with the indicated cells.
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Fig. 6. Inhibition of SDF-1-CXCR4 signaling reduces immune cell recruitment into livers of HBx-TG. Recruitment of immune cells to liver is reduced by injection of CXCR4
antagonist in HBx-TG mice. H&E staining was performed on parafﬁn-embedded liver tissue sections of HBx-TG mice injected with PBS (n = 3) or AMD3100 (n = 4).
738 H.K. Cho et al. / FEBS Letters 588 (2014) 733–739activity in a dose dependant manner (Fig. 4D) and bound on SDF-1
promoter (Fig. 4F). These results suggest that XBP1 up-regulates
SDF-1 expression by binding on SDF-1 promoter.
3.5. HBx-induced SDF-1 expression is mediated by XBP1
To further conﬁrm that HBx-induced SDF-1 expression is med-
iated by XBP1, we performed knock-down of XBP1 gene expression
using siRNA against XBP1. As shown in Fig. 5A, SDF-1 induction by
HBx was attenuated by XBP1 knock-down, suggesting that HBx-
activated XBP1 protein increases SDF-1 expression. In addition to
RNAi, we conﬁrmed XBP1 function in HBx-induced SDF-1 expres-
sion by using XBP1 +/+ and XBP1 / MEF cells. HBx-induced
SDF-1 gene transactivation was not observed in XBP1 / MEFs
based on SDF-1 promoter activity (Fig. 5B). To further conﬁrm this,
we infected Ad-HBx expression construct into both MEFs. Consis-
tent with the result of Fig. 5B, Ad-HBx infection largely increased
SDF-1 induction in XBP1 +/+ MEFs, but not in XBP1 / MEFs
(Fig. 5C). Protein expression of SDF-1 was also up-regulated in
Ad-HBx-infected XBP1 +/+ MEF cells (Fig. 5D). These results suggest
that HBx-induced SDF-1 expression is mediated by XBP1 in the
cells.
3.6. Inhibition of SDF-1-CXCR4 signaling reduces immune cell
recruitment into livers of HBx-TG mice
CXCR4 is a GPCR speciﬁc to SDF-1 [20,21] and is inhibited by the
soluble inhibitor AMD3100. Many recent studies have reported
that AMD3100 speciﬁcally inhibits SDF-1-mediated responses
[22]. To conﬁrm the physiological role of SDF-1 in HBx-induced
recruitment of immune cells, we treated PBS or AMD3100 to
HBx-TG mice through subcutaneous injection. As shown in Fig. 6,
whereas many immune cells were recruited to livers of HBx-TG
mice injected with PBS, AMD3100 signiﬁcantly inhibited immune
cell recruitment. These results suggest that increased recruitment
of immune cells in HBx-TG mice is mediated by SDF-1 signaling.
4. Discussion
In early HBV infection, NK and NKT cells, which recognize one
or more viral product, may stimulate the early innate immune de-
fense response [7]. Activated NK and NKT cells may be involved in
the killing of infected cells, production of cytokines and chemo-
kines, and activation of the adaptive immune response [23].
HBV-speciﬁc CTLs play key roles in antiviral immunity by killing
infected cells, producing cytokines and chemokines, inhibiting vir-
al replication, and performing viral clearance [1,24]. Therefore, theearly innate immune defense response does not signiﬁcantly con-
tribute to the pathogenesis of liver disease [1]. Although
hepatocellular injury is clearly initiated by cytopathic activity of
HBV-speciﬁc CTLs, liver tissue displays more severe damage in
chronically HBV-infected patients, suggesting that CTLs or chroni-
cally HBV-infected cells may perform additional functions [2].
Many researchers have reported that ER stress induces the
inﬂammatory response. In particular, IRE1a may play a more
important role than either PERK or ATF6, which are conserved
branches of the unfolded protein response, in ER stress-induced
inﬂammation [25]. In response to ER stress, IRE1a forms a complex
with the adaptor protein TNFa receptor-associated factor 2
(TRAF2) [25] for the recruitment of IjB kinase (IKK), leading to
IjB degradation through IjB phosphorylation. Activated NF-jB
then translocates into the nucleus whereupon it induces the
expression of inﬂammatory genes [26]. Furthermore, the IRE1a-
TRAF2 complex recruits and activates c-Jun N-terminal kinase
(JNK), which then phosphorylates activator protein1 followed by
induction of inﬂammatory gene expression [27]. According to
recent reports, XBP1 enhances the production of inﬂammatory
cytokines, including IL-6 and TNF [28]. Based on our current result
that XBP1 induces chemokine SDF-1 expression, the IRE1a/XBP1
pathway may provide a link between ER stress and inﬂammation.
HBV has different strategies for escaping the immune response
[29]. Firstly, HBV encodes structural and non-structural proteins
that promote its ampliﬁcation. Secondly, HBV replicates by estab-
lishing a pool of stable extrachromosomal transcription templates.
Thirdly, HBV replicates in the liver, which is an immunopriviledged
site. Therefore, in addition to elimination of HBV genome or inhibi-
tion of HBV replication, inhibition of antigen-nonspeciﬁc immune
cell recruitment may present a new direction for treating chroni-
cally HBV-infected patients. Further, many studies have reported
that the inﬂammatory response is attenuated by AMD3100, which
inhibits inﬁltration of immune cells into tissues [22,30]. This sug-
gests that inhibitors that target chemokine or chemokine receptors
are a potential therapy for the treatment of chronically HBV-in-
fected patients.
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